BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liao Z, Huang C, Zhou F, Xiong J, Bao J, Zhang H, Sun W, Xie C, Zhou Y. Radiation enhances suicide gene therapy in radioresistant laryngeal squamous cell carcinoma via activation of a tumor-specific promoter. Cancer Lett. 2009;283:20-28. [PMID: 19375219 DOI: 10.1016/j.canlet.2009.03.021] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Shin J, Foot T, Hong A, Zhang M, Lum T, Solomon MJ, Soon Lee C. Telomerase expression as a predictive marker of radiotherapy response in rectal cancer: in vitro and in vivo study. Pathology 2012;44:209-15. [DOI: 10.1097/pat.0b013e3283511cd5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
2 Ouellette MM, Wright WE, Shay JW. Targeting telomerase-expressing cancer cells. J Cell Mol Med 2011;15:1433-42. [PMID: 21332640 DOI: 10.1111/j.1582-4934.2011.01279.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 4.9] [Reference Citation Analysis]
3 Guijin H, QiYong G, XiaoDan Z, DaWei J, Xi G, ChunLai P, Liu W, XianWei D. Effect of 103Pd radioactive stent on caspase-9, cholangiocarcinoma cell growth and its radiosensitivity. Surg Oncol. 2011;20:247-251. [PMID: 20231087 DOI: 10.1016/j.suronc.2010.02.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
4 Yu DS, Zhao W, Huang HZ, Hu XW, Liu XQ, Tang HK. Synthetic radiation-inducible promoters mediated HSV-TK/GCV gene therapy in the treatment of oral squamous cell carcinoma. Oral Dis 2010;16:445-52. [PMID: 20412454 DOI: 10.1111/j.1601-0825.2010.01655.x] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
5 Xu Y, Hou J, Liu Z, Yu H, Sun W, Xiong J, Liao Z, Zhou F, Xie C, Zhou Y. Gene therapy with tumor-specific promoter mediated suicide gene plus IL-12 gene enhanced tumor inhibition and prolonged host survival in a murine model of Lewis lung carcinoma. J Transl Med 2011;9:39. [PMID: 21481255 DOI: 10.1186/1479-5876-9-39] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
6 Takahashi H, Hyakusoku H, Horii C, Takahashi M, Nishimura G, Taguchi T, Kondo N, Sakakibara A, Urata Y, Sano D. Telomerase-specific oncolytic adenovirus: antitumor effects on radiation-resistant head and neck squamous cell carcinoma cells. Head Neck 2014;36:411-8. [PMID: 23728900 DOI: 10.1002/hed.23309] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
7 Chen G, Tang B, Yang BY, Chen JX, Zhou JH, Li JH, Hua ZC. Tumor-targeting Salmonella typhimurium, a natural tool for activation of prodrug 6MePdR and their combination therapy in murine melanoma model. Appl Microbiol Biotechnol 2013;97:4393-401. [PMID: 22868826 DOI: 10.1007/s00253-012-4321-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
8 Buseman CM, Wright WE, Shay JW. Is telomerase a viable target in cancer? Mutat Res. 2012;730:90-97. [PMID: 21802433 DOI: 10.1016/j.mrfmmm.2011.07.006] [Cited by in Crossref: 87] [Cited by in F6Publishing: 78] [Article Influence: 7.9] [Reference Citation Analysis]
9 Humer D, Spadiut O. Enzyme prodrug therapy: cytotoxic potential of paracetamol turnover with recombinant horseradish peroxidase. Monatsh Chem 2021;152:1389-97. [PMID: 34759433 DOI: 10.1007/s00706-021-02848-x] [Reference Citation Analysis]
10 Lv JL, Gao N, Li F, He W, Shang JL. Combined use of indole-3-acetic acid and horseradish peroxidase inhibits the growth of human adenoid cystic carcinoma SACC-2 cells. Shijie Huaren Xiaohua Zazhi 2009; 17(23): 2413-2416 [DOI: 10.11569/wcjd.v17.i23.2413] [Reference Citation Analysis]
11 Kim S, Youn H, Song MG, Kang JH, Chung HK, Lee DS, Chung JK. Complementary treatment of siTERT for improving the antitumor effect of TERT-specific I-131 therapy. Cancer Gene Ther. 2012;19:263-270. [PMID: 22301953 DOI: 10.1038/cgt.2011.88] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
12 Humer D, Furlanetto V, Schruef AK, Wlodarczyk A, Kuttke M, Divne C, Spadiut O. Potential of unglycosylated horseradish peroxidase variants for enzyme prodrug cancer therapy. Biomed Pharmacother 2021;142:112037. [PMID: 34392084 DOI: 10.1016/j.biopha.2021.112037] [Reference Citation Analysis]
13 Si L, Zheng L, Xu L, Yin L, Han X, Qi Y, Xu Y, Wang C, Peng J. Dioscin suppresses human laryngeal cancer cells growth via induction of cell-cycle arrest and MAPK-mediated mitochondrial-derived apoptosis and inhibition of tumor invasion. European Journal of Pharmacology 2016;774:105-17. [DOI: 10.1016/j.ejphar.2016.02.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
14 Karjoo Z, Chen X, Hatefi A. Progress and problems with the use of suicide genes for targeted cancer therapy. Adv Drug Deliv Rev 2016;99:113-28. [PMID: 26004498 DOI: 10.1016/j.addr.2015.05.009] [Cited by in Crossref: 80] [Cited by in F6Publishing: 78] [Article Influence: 11.4] [Reference Citation Analysis]